News Drugs could mimic gut bacteria benefits to treat diabetes It may be possible to design drugs that mimic the positive health benefits of gut bacteria to treat diseases such as type II diabetes, a new study has found.
Partner Content Partner Content Review Microbiome Start-Up Success Stories & Business Models Your Invite - Microbiome Start-Up Focus Evening
Partner Content Partner Content Regulatory Guidance for Microbiome-Based Therapeutics Join The Microbiome Movement
Partner Content Partner Content An Interview with Chris Damman, Bill & Melinda Gates Foundat... The Microbiome Movement recently had the delight of interviewing Chris Damman from the Bill & Melinda Gates Foundation and discussed his career, resea
Partner Content Partner Content Personal Highlights – Microbiome Movement – Maternal & I... Discovering The Maternal-Infant Microbiome
Partner Content Partner Content 5 Leaders, 1 Panel: Microbiome Movement - Drug Development S... 5 Leaders, 1 Panel: Join The Microbiome Movement
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.